Development of multidrug resistance protein inhibitors

Drugs of the Future

Volumn 22, Issue 6, 1997, Pages 653-660

  Reddy, Doodipala S ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; ANTISENSE OLIGODEOXYNUCLEOTIDE; BUTHIONINE SULFOXIMINE; CARRIER PROTEIN; CYCLOSPORIN; DAUNORUBICIN; DIFLOXACIN; DOXORUBICIN; ETOPOSIDE; GENISTEIN; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PEPTIDE 190; NICARDIPINE; NIK 250; PODOPHYLLOTOXIN DERIVATIVE; QUINIDINE; UNCLASSIFIED DRUG; VALSPODAR; VERAPAMIL; VERLUKAST; VINCA ALKALOID; VINCRISTINE;

DRUG DEVELOPMENT; DRUG SENSITIZATION; DRUG TRANSPORT; GENE OVEREXPRESSION; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN STRUCTURE; REVIEW;

EID: 0030797888     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (87)

1. Senior, A.E., Al-Shawi, M.K., Urbatsch, I.L. The catalytic cycle of P-glycoprotein. FEBS Lett 1995, 377: 285-9.
2. Endicott, J.A., Ling, V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 1989, 58: 137-71.
3. Arceci, R.J. Clinical significance of P-glycoprotein in multidrug resistance malignancies. Blood 1993, 81: 2215-22.
4. Chin, K-V., Pastan, I., Gottesman, M.M. Function and regulation of the human multidrug resistance gene. Adv Cancer Res 1993, 60: 157-80.
5. Deffie, A.M., Alam, T., Seneviratne, C. et al. Multifactorial resistance to adriamycin: Relationship of DNA repair, glutathione transferase activity, drug efflux and P-glycoprotein in cloned cell lines of adriamycin-sensitive and resistant P388 leukemia. Cancer Res 1988, 48: 3595-602.
6. Ganapathi, R., Grabowksi, D., Ford, J.M., Heiss, C., Kerrigan, D., Pommier, Y. Progressive resistance to doxorubicin in murine leukemia L1210 cells with multidrug resistance phenotype: Reductions in drug-induced topoisomerase II-mediated DNA cleavage. Cancer Commun 1989, 1: 217-24.
7. Szczypka, M.S., Wemmie, J.A., Moye-Rowley, W.S., Thiele, D.J. A yeast metal resistance protein similar to human cystic fibrosis transmembrane conductance regulator and multidrug resistance-associated protein. J Biol Chem 1994, 269: 22853-7.
8. Gottesman, M.M., Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993, 62: 385-427.
9. Higgins, C.F., Gottesman, M.M. Is the multidrug transporter a flip-pase? Trends Biochem Sci 1992, 17: 18-21.
10. Roepe, P.D. The role of the MDR protein in altered drug translocation across tumor cell membranes. Biochim Biophys Acta 1995, 1241: 385-406.
11. Lautier, D., Canitrot, Y., Deeley, R.G., Cole, S.P.C. Multidrug resistance mediated by the multidrug resistance protein (MRP) gene. Biochem Pharmacol 1996, 52: 967-77.
12. Cole, S.P.C., Bhardwaj, G., Gertach, J.H. et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992, 258: 1650-4.
13. Cole, S.P.C., Chanda, E.R., Dicke, E.P. et al. Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line: Evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II. Cancer Res 1991, 51: 3345-52.
14. Cole, S.P.C. The 1991 Merck Frosst Award. Multidrug resistance in small cell lung cancer. Can J Physiol Pharmacol 1992, 70: 313-29.
15. Mirski, S.E.L., Gerlach, J.H., Cole, S.P.C. Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin. Cancer Res 1987, 47: 2594-8.
16. Higgins, C.F. ABC transporters: From microorganisms to man. Annu Rev Cell Biol 1992, 8: 67-113.
17. Paulusma, C.C., Bosma, P.J., Zaman, G.J.R. et al. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science 1996, 27: 1126-8.
18. Stride, B.D., Valdimarsson, G. Gerlach, J.H. et al. Structure and expression of the mRNA encoding the murine multidrug resistance protein (MRP), an ATP-binding cassette transporter. Mol Pharmacol 1996, 49: 962-71.
19. Almquist, K.C., Loe, D.W., Hipfner, D.R. et al. Characterization of the 190 kDa multidrug resistance protein (MRP) in drug-selected and transfected human tumor cells. Cancer Res 1995, 55: 102-10.
20. Ma, L., Krishamachary, N., Center, M.S. Phosphorylation of the multidrug resistance associated protein gene encoded protein P190. Biochemistry 1995, 34: 3338-43.
21. Versandort, C.H.M., Broxterman, H.J., Pinedo, H.M. et al. Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant lung cancer cell lines without P-glycoprotein expression. Cancer Res 1992, 52: 17-23.
22. Schneider, E., Horton, J.K., Yang, C-H. et al. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance. Cancer Res 1994, 54: 152-8.
23. Barrand, M.A., Robertson, K.J., Neo, S-Y. et al. Localisation of the multidrug resistance-associated protein, MRP, in resistant large-cell lung tumor cells. Biochem Pharmacol 1995, 50: 1725-9.
24. Flens, M.J., Izquerdo, M.A., Scheffer, G.L. Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. Cancer Res 1994, 54: 4557-63.
25. Marquardt, D., Center, M.S. Drug transport mechanisms in HL60 cells isolated for resistance to adriamycin: Evidence for nuclear drug accumulation and redistribution in resistant cells. Cancer Res 1992, 52: 3157-63.
26. Flens, M.J., Zaman, G.J.R., Van der Valk, P. et al. Tissue distribution of the multidrug resistance protein. Am J Pathol 1996, 148: 1237-47.
27. Krishamachary, N., Center, M.S. The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Res 1993, 53: 3658-61.
28. Coley, H.M., Amos, W.B., Twentyman, P.R., Workman, P. Examination by laser scanning confocal fluorescence imaging microscopy of the subcellular localization of anthracyclines in parent and multidrug resistant cell lines. Br J Cancer 193, 67: 1316-23.
29. Cole, S.P.C., Sparks, K.E., Fraser, K. et al. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res 1994, 54: 5902-10.
30. Rhodes, T., Barrand, M.A., Twentymann, P.R. Modification by brefeldin A, bafilomycin A1 and 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (NBD) of cellular accumulation and intracellular distribution of anthracyclines in the non-P-glycoprotein-mediated multidrug-resistant cell line COR-L23/R. Br J Cancer 1994, 70: 60-6.
31. Sehested, M., Skovsgaard, T., Van Deurs, B., Winther-Nielsen, H. Increased plasma membrane traffic in daunorubicin resistant P388 leukaemic cells. Effect of daunorubicin and verapamil. Br J Cancer 1987, 56: 747-51.
32. Roepe, P.D., Wei, L.Y., Cruz, J., Carlson, D. Lower electrical membrane potential and altered pH homeostasis in multidrug-resistant (MDR) cells: further characterization of series of MDR cell lines expressing different levels of P-glycoprotein. Biochemistry 1993, 32: 11042-56.
33. Thiebaut, F., Currier, S.J., Whitaker, J. et al. Activity of the multidrug transporter results in alkalinization of the cytosol: Measurement of cytosolic pH by microinjection of a pH-sensitive dye. J Histochem Cytochem 1990, 38: 685-90.
34. Keizer, H.G., Joenje, H. Increased cytosolic pH in multidrug-resistant human lung tumor cells: Effect of verapamil. J Natl Cancer Inst 1989, 81: 706-9.
35. Leier, I., Jedlitshky, G., Buchholz, U. et al. ATP-dependent glutathione disulfide transport mediated by the MRP gene-encoded conjugate export pump. Biochem J 1996, 314: 433-7.
36. Jedlitschky, G., Leier, I., Buchholz, U. et al. Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res 1996, 56: 988-94.
37. 4 and structurally related conjugates. J Biol Chem 1994, 269: 27807-10.
38. Jediltschky, G., Leier, I., Buchholz, U., Center, M., Keppler D. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res 1994, 54: 4833-6.
39. Muller, M., Meijer, C., Zaman, G.J.R. et al. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc Natl Acad Sci USA 1994, 91: 13033-7.
40. 4 and chemotherapeutic agents in membrane vesicles: Demonstration of glutathione-dependent vincristine transport. J Biol Chem 1996, 271: 9675-82.
41. McGrath, T., Latoud, C., Arnold, S.T. et al. Mechanisms of multidrug resistance in HL60 cells: Analysis of resistance associated membrane proteins and levels of mdr gene expression. Biochem Pharmacol 1989, 38: 3611-9.
42. Versantvoort, C.H.M., Broxterman, H.J., Bagrij, T., Scheper, R.J., Twentyman, P.R. Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein. Br J Cancer 1995, 72: 82-9.
43. Lahmy, S., Lautier, D., Canitrot, Y., Laurent, G., Salmon, J-M. Staining with Hoechst 3342 and rhodamine 123: An attempt to detect multidrug resistant phenotype cells in leukemia. Leuk Res 1993, 17: 1021-9.
44. Canitrot, Y., Lautier, D., Viallet, P., Salmon J-M. Modulation of rhodamine 123 uptake by nigericin in sensitive and multidrug resistant leukemic cells. Cancer Lett 1994, 84: 75-83.
45. Neyfakh, A.A. Use of fluorescent dyes as molecular probes for the study of multidrug resistance. Exp Cell Res 1988, 174: 168-76.
46. Weaver, J.L., Pine, P.S., Aszalos, A. et al. Laser scanning and confocal microscopy of daunorubicin, doxorubicin, and rhodamine 123 in multidrug-resistant cells. Exp Cell Res 1991, 196: 323-9.
47. Cole, S.P.C. Patterns of cross-resistance in a multidrug-resistant small-cell lung carcinoma cell line. Cancer Chemother Pharmacol 1990, 26: 250-6.
48. Loe, D.W., Deeley, R.G., Cole, S.P.C. Biology of drug resistance associated with overexpression of the multidrug resistance protein. MRP. Eur J Cancer 1996, 32A: 945-57.
49. Hasegawa, S., Abe, T., Naito, S. et al. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines. Br J Cancer 1995, 71: 907-13.
50. Brock, I., Hipfner, D.R., Nielsen, B.S. et al. Sequential coexpression of the multidrug resistance genes MRP and mdr1 and their products in VP-16 (etoposide)-selected H69 small cell lung cancer cells. Cancer Res 1995, 55: 459-62.
51. Slapak, C.A., Mizunuma, N., Kufe, D.W. Expression of the multidrug resistance associated protein and P-glycoprotein in doxorubicin-selected human myeloid leukemia cells. Blood 1994, 84: 3113-21.
52. Hardy, S.P., Goodfellow, H.R., Valverde, M.A., Gill, D.R., Sepulveda, F.V., Higgins, C.F. Protein kinase-C-mediated phosphorylation of the human multidrug resistance P-glycoprotein regulates cell volume-activated chloride channels. EMBO J 1995, 14: 68-75.
53. Abraham, E.H., Prat, A.G., Gerweck, L. et al. The multidrug resistance (mdr1) gene product functions as an ATP channel. Proc Natl Acad Sci USA 1993, 90: 312-6.
54. Schwiebert, E.M., Egan, M.E., Hwang, T-H. et al. CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP. Cell 1995, 18: 1063-73.
55. - exchange in transfected Chinese hamster ovary cells. Biochemistry 1994, 33: 7239-49.
56. Devault, A., Gros, P. Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities. Mol Cell Biol 1990, 10: 1652-62.
57. Wei, L.Y., Stutts, M.J., Hoffman, M.M., Roepe, P.D. Overexpression of the CFTR in NIH 3T3 cells lowers membrane potential and intracellular pH and confers a multidrug resistance phenotype. Biophys J 1995, 69: 883-95.
58. Mayer, L.D., Bally, M.B., Hope, M.J., Cullis, P.R. Uptake of dibucaine into large unilamellar vesicles in response to a membrane potential. J Biol Chem 1985, 260: 802-8.
59. Versantvoort, C.H.M., Broxterman, H.J., Pinedo, H.M. et al. Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant human lung cancer cell lines without P-glycoprotein expression. Cancer Res 1992, 52: 17-23.
60. Sirotnak, F.M., Yang, C-H., Mines, L.S., Oribe, E., Biedler, J.L. Markedly altered membrane transport and intracellular binding of vincristine in multidrug-resistant Chinese hamster cells selected for resistance to vinca alkaloids. J Cell Physiol 1986, 126: 266-74.
61. Robinson, L.J., Roepe, P.D. Effects of membrane potential versus pH on the cellular retention of doxorubicin analyzed via a comparison between cystic fibrosis transmembrane conductance regulator (CFTR) and multidrug resistance (MDR) transfectants. Biochem Pharmacol 1996, 52: 1081-95.
62. Nooter, K., Westerman, A.M., Flens, M.J. et al. Expression of the multidrug resistance-associated protein (MRP) gene in human cancers. Clin Cancer Res 1995, 1: 1301-10.
63. Kruh, G.D., Gaughan, K.T., Godwin, A., Chan, A. Expression pattern of MRP in human tissues and adult solid tumor cell lines. J Natl Cancer Inst 1995, 87: 1256-8.
64. Ramu, A., Fuks, Z., Gatts, S., Glaubiger, D. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate. Cancer Res 1984, 44: 144-8.
65. Cornwell, M.M., Gottesman, M.M., Pastan, I. Increased vinblastine binding to membrane vesicles from multidrug resistant KB cells. J Biol Chem 1986, 261: 7921-8.
66. Panasci, L., Jean-Claude, B.J., Vasilescu, D. et al. Sensitization to doxorubicin resistance in breast cancer cell lines by tamoxifen and megestrol acetate. Biochem Pharmacol 1996, 52: 1097-102.
67. Ramu, A., Glaubiger, D., Fuks, Z. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by tamoxifen and other triparanol analogues. Cancer Res 1984, 44: 4392-5.
68. Ford, F.M., Hait, W.N. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol Rev 1991, 4: 155-9.
69. Barrand, M.A., Rhodes, T., Center, M.S., Twentyman, P.R. Chemosensitization and drug accumulation effects of cyclosporin A, PSC-833 and verapamil in human MDR large cell lung cancer cells expressing a 190k membrane protein distinct from P-glycoprotein. Eur J Cancer 1993, 29A: 408-15.
70. Gollapudi, S., Gupta, S. Lack of reversal of daunorubicin resistance in HL60/AR cells by cyclosporin A. Anticancer Res 1992, 12: 2127-32.
71. Abe, T., Koike, K., Ohga, T. et al. Chemosensitization of spontaneous multidrug resistance by a 1,4-dihydropyridine analog and verapamil in human glioma cell lines overexpressing MRP or MDR1. Br J Cancer 1995, 72: 418-23.
72. Cole, S.P.C. Downes, H.F., Slovak, M.L. Effect of calcium antagonists on the chemosensitivity of two multidrug resistant human tumour cell lines which do not overexpress P-glycoprotein. Br J Cancer 1989, 59: 42-6.
73. Gekeler, V., Boer, R., Ise, W. et al. The specific bisindolylmaleimide PKC-inhibitor GF-109203X efficiently modulates MRP associated multiple drug resistance. Biochem Biophys Res Commun 1995, 206: 119-26.
74. Gollapudi, S., Thadepalli, F., Kim, C.H., Gupta, S. Difloxacin reversed multidrug resistance in HL-60/AR cells that overexpress the multidrug resistance-related protein (MPP) gene. Oncol Res 1995, 7: 213-25.
75. Gekeler, V., Ise, W., Sanders, K.H., Ulrich, W.R., Beck, J. The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance. Biochem Biophys Res Commun 1995, 208: 345-52.
76. Versandort, C.H.M., Broxterman, H.J., Lankelma, J. et al. Competitive inhibition by genistein and ATP dependence of daunorubicin transporting intact MRP overexpressing human small cell lung cancer cells. Biochem Pharmacol 1994, 48: 1129-36.
77. Versandort, C.H.M., Lankelma, J., Broxterman, H. Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumor cells. Br J Cancer 1993, 68: 939-46.
78. Wu, J., Furusawa, S., Nakano, S. et al. Reversal of multidrug resistance by tacrolimus hydrate. Meth Find Exp Clin Pharmacol 1996, 18: 651-8.
79. Cole, S.P.C., Downes, H.F., Mirski, S.E.L., Clements, D.J. Alterations in glutathione and glutathione-related enzymes in a multidrug resistant small cell lung cell line. Mol Pharmacol 1990, 37: 192-7.
80. Zaman, G.J.R., Lankelma, J., Van Tellingen, O. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc Natl Acad Sci USA 1995, 92: 7690-4.
81. Schneider, E., Yamazaki, H., Sinha, B.K., Cowan, K.H. Buthionine sulfoxime-mediated sensitization of etoposide-resistant human breast cancer MCF7 cells overexpressing the multidrug resistance-associated protein involves increased drug accumulation. Br J Cancer 1995, 71: 738-43.
82. Davey, R.A., Longhurst, T.J. Davey, M.W. et al. Drug resistance mechanisms and MRP expression in response to epirubicin treatment in a human leukemia cell line. Leuk Res 1995, 19: 275-82.
83. Lutzky, J., Astor, M.B., Taub, R.N. Role of glutathione and dependent enzymes in anthracycline-resistant HL60/AR cells. Cancer Res 1989, 49: 4120-5.
84. Kiehntopf, M., Brach, M.A., Licht, T. et al. Ribozyme-mediated cleavage of the MDR-1 transcript restores chemosensitivity in previously resistant cancer cells. EMBO J 1994, 13: 4645-52.
85. Holm, P.S., Dietel, M., Krupp, G. Similar cleavage efficiencies of an oligoribonucleotide substrate and an mdr1 mRNA segment by a hammerhead ribozyme. Gene 1995, 167: 221-5.
86. Stewart, A.J., Canitrot, Y., Baracchini, E. et al. Reductions in the expression of the multidrug resistance protein MRP, in human tumor cells by antisense phosphorothioate oligonucleotides. Biochem Pharmacol 1996, 51: 461-9.
87. Quattrone, A., Papucci, L., Morganti, M. et al. Inhibition of MDR1 gene expression by antimessenger oligonucleotides lowers multiple drug resistance. Oncol Res 1994, 6: 311-20.